New FDA-cleared Lung Guidance and AutoAS algorithms bring real-time scanning navigation and aortic stenosis detection directly to handheld point-of-care ultrasound devices for faster bedside triage.

Allia Celeo pairs an extra-wide-bore ceiling C-arm with an AI-powered image chain and predictive analytics to streamline interventional cardiology and radiology workflows.

Leading institutions will evaluate StarGuide GX across quantitative imaging, dynamic imaging and emerging theranostic applications.

GE HealthCare introduced LOGIQ Focus to accelerate diagnostic throughput and enhance tissue characterization across general imaging, primary care, and specialized diagnostics.

GE HealthCare End-tidal Control software on Aisys CS2 workstations automates fresh gas flow and volatile anesthetic regulation in hospital operating rooms.

GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron and expanded the PETtrace Solid Target Platform to Copper-64.

This collaborative research applies generative artificial intelligence to synthesize clinical data, enabling personalized oncology workflows and accelerating patient progression from diagnosis to treatment.

GE HealthCare introduced a cloud application to forecast hospital capacity constraints, deploying machine learning models across health system networks.

GE HealthCare has submitted the StarGuide GX 4D CZT SPECT/CT system for U.S. FDA 510(k) clearance, aiming to expand advanced molecular imaging and theranostics capabilities following its recent European CE Mark.

GE HealthCare introduced three cardiovascular ultrasound systems engineered to standardize beamforming architecture and automated diagnostic quantification across varied clinical healthcare settings.